Zimmer Biomet Holdings, Inc. (SWX:ZBH)
72.00
0.00 (0.00%)
At close: Aug 13, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Knees Net Sales | 3.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Knees Net Sales Growth | 3.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hips Net Sales | 2.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hips Net Sales Growth | 3.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
S.E.T. Net Sales | 1.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
S.E.T. Net Sales Growth | 9.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Technology & Data, Bone Cement and Surgical Net Sales | 640.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Technology & Data, Bone Cement and Surgical Net Sales Growth | -4.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Spine & Dental Net Sales | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Spine & Dental Net Sales Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2011 - 2018 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2011 - 2018 |
EMEA Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Pacific Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Pacific Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Orthopedics Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Orthopedics Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Spine & Global Dental Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Spine & Global Dental Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Americas Segment Profit | 2.58B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Segment Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA Segment Profit | 585.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA Segment Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Pacific Segment Profit | 457.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Pacific Segment Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
EMEA Net Sales | 1.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA Net Sales Growth | 5.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Pacific Net Sales | 1.19B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Pacific Net Sales Growth | 4.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Orthopedics Net Sales | 4.79B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Orthopedics Net Sales Growth | 3.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Spine & Global Dental Net Sales | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Spine & Global Dental Net Sales Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|